每年研究成果
每年研究成果
- 2結果
搜尋結果
-
2018
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994
Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., 8月 17 2018, 於: Oncotarget. 9, 64, p. 32403 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
3 引文 斯高帕斯（Scopus） -
2016
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455
Hsieh, Y. Y., Huang, T. C., Lo, H. L., Jhan, J. Y., Chen, S. T. & Yang, P. M., 5月 10 2016, 於: Oncotarget. 9, 64, p. 32402 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審